Business Context and Reporting Period
Company: Amalgamated Financial Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 19, 2025 (Earliest event reported)
Reporting Period: Specific corporate governance and executive compensation events occurring in March 2025.
Key Financial Metrics
This filing does not contain general financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements and employment terms.
Material Changes and Executive Compensation
Bonus Deferral Plan Adoption
- Effective Date: March 19, 2025.
- Structure: Nonqualified Bonus Deferral and Deferred Stock Unit (DSU) Program for eligible executives.
- Deferral Terms: Executives may defer up to 100% of their annual incentive bonus into DSUs.
- Company Match: 100% match up to 35% of the deferred bonus amount in additional DSUs.
- Vesting: Voluntary DSUs are fully vested; matching DSUs are subject to vesting based on age, years of service, and a one-year minimum requirement.
- Payout: Lump sum or installments up to five years upon separation, change of control, or qualifying financial emergency.
CEO Employment Agreement Amendment
- Executive: Priscilla Sims Brown, President & CEO.
- Agreement Date: March 25, 2025 (Amending May 10, 2021 agreement).
- Term: 36 full calendar months, with automatic 12-month renewals unless 90 days' notice is given.
- Base Salary: $1,080,000 annually (effective Jan 1, 2025).
- Annual Target Bonus: 80% of base salary ($864,000).
- Equity Target Grant: Aggregate potential value of $1,560,000.
- 2025: 50% time-based vesting, 50% time and performance-based.
- 2026+: 40% time-based vesting, 60% time and performance-based.
- Legal Fee Reimbursement: Up to $10,605 for negotiation expenses.
Severance Provisions
- Standard Termination (Without Cause/Good Reason):
- 12 months of base salary.
- 100% of Annual Target Bonus for the fiscal year of termination.
- Pro-rated Annual Target Bonus for the prior fiscal year.
- Payment over 12 months; includes COBRA coverage for 12 months.
- Change in Control (CIC) Termination:
- 21 months of base salary.
- 175% of Annual Target Bonus.
- Payment over 21 months.
- Exclusions: No severance for termination for Cause, death, disability, or voluntary resignation without Good Reason.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates a strategic focus on executive retention through enhanced equity deferral options and a formalized long-term employment structure for the CEO.
Risks and Contingencies:
- Financial Contingency: Significant cash outflows are contingent upon specific termination events (Without Cause, Good Reason, or Change in Control).
- Equity Dilution: The Bonus Deferral Plan and CEO equity grants will result in the issuance of new shares under the 2023 Equity Plan.
- Restrictive Covenants: The CEO is subject to non-competition and non-solicitation restrictions for the longer of 12 months or the severance payment period.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2023 Equity Plan to assess dilution impact from the new Bonus Deferral Plan and CEO grants.
- Review the full text of Exhibit 10.4 (Brown Amended & Restated Employment Agreement) for specific definitions of "Cause," "Good Reason," and "Change in Control."
- Confirm the vesting schedule details for the CEO's performance-based equity awards to understand future compensation obligations.
- Monitor future filings for the actual grant date and valuation of the $1,560,000 Target Grant to the CEO.